Serine/arginine-rich splicing factor 3 (SRSF3) likely has wide-ranging roles in gene expression and facilitation of tumor cell growth. SRSF3 knockdown induced G1 arrest and apoptosis in colon cancer cells (HCT116) in association with altered expression of 833 genes. Pathway analysis revealed 'G1/S Checkpoint Regulation' as the most highly enriched category in the affected genes. SRSF3 knockdown did not induce p53 or stimulate phosphorylation of p53 or histone H2A.X in wild-type HCT116 cells. Furthermore, the knockdown induced G1 arrest in p53-null HCT116 cells, suggesting that p53-dependent DNA damage responses did not mediate the G1 arrest. Real-time reverse transcription-polymerase chain reaction and western blotting confirmed that SRSF3 knockdown reduced mRNA and protein levels of cyclins (D1, D3 and E1), E2F1 and E2F7. The decreased expression of cyclin D and E2F1 likely impaired the G1-to-S-phase progression. Consequently, retinoblastoma protein remained hypophosphorylated in SRSF3 knockdown cells. The knockdown also induced apoptosis in association with reduction of BCL2 protein levels. We also found that SRSF3 knockdown facilitated skipping of 81 5 0 -nucleotides (27 amino acids) from exon 8 of homeodomain-interacting protein kinase-2 (HIPK2) and produced a HIPK2 De8 isoform. Full-length HIPK2 (HIPK2 FL) is constantly degraded through association with an E3 ubiquitin ligase (Siah-1), whereas HIPK2 De8, lacking the 27 amino acids, lost Siah-1-binding ability and became resistant to proteasome digestion. Interestingly, selective knockdown of HIPK2 FL induced apoptosis in various colon cancer cells expressing wild-type or mutated p53. Thus, these findings disclose an important role of SRSF3 in the regulation of the G1-to-S-phase progression and alternative splicing of HIPK2 in tumor growth.
INTRODUCTION
The serine/arginine-rich splicing factor (SRSF) family comprises at least 12 evolutionarily conserved and structurally related RNAbinding proteins (SRSF1-12).
1 SRSF proteins bind cis-acting RNA elements through one or two N-terminal RNA recognition motifs, whereas a C-terminal region enriched in serine-arginine dipeptides (SR domain) mediates interactions with other proteins for the regulation of both constitutive and alternative splicing of premRNA. 2 Moreover, SRSF family members have wide-ranging roles in the regulation of transcription and post-splicing processes, including RNA elongation, 3 mRNA polyadenylation, 4 mRNA transport, 5 nonsense-mediated mRNA decay 6 and translation. 7 These extensive roles are essential for proper cell cycle control. At the same time, overexpressed SRSFs, particularly SRSF1 (ASF/SF2), likely possess oncogenic activities. 8, 9 Individual SRSF proteins have different target mRNAs and distinct functions. Their specific roles in the regulation of cell fate have been investigated in gene-targeting experiments. The loss of SRSF1 or SRSF2 causes cell cycle defects through multiple mechanisms. Their deficiency markedly reduces the production of nascent RNAs and causes global transcriptional defects including cell cycle-related genes. 3, 10 In SRSF1-or SRSF2-deficient cells, nascent RNA is not displaced from template DNA, formation of R-loops is facilitated, and double-strand DNA breaks increase. Resultant DNA damage responses (DDRs) lead to G2/M cell cycle arrest. [11] [12] [13] An alternative splicing network is also closely related to cell cycle control and apoptosis. SRSF1 downregulation changes alternative splicing of several BCL2 family pre-mRNAs to yield their proapoptic forms.
14 These knockout and knockdown experiments indirectly suggest potential roles of SRSFs in cancer cell growth. Cancer cells often show aberrant alternative splicing profiles. 15 Some of the changes may result from mutations at splice sites or splicing regulatory elements of genes crucial for tumorigenesis. Others may be caused by altered expression of splicing factors as reported in colon, 9 ovarian 16, 17 and breast cancers. 18 Recently, it has been shown that moderately overexpressed SRSF1 promotes mammary epithelial cell transformation. 8 SRSF3 (SRp20) is essential for development, as mouse embryos lacking SRSF3 could not form blastocysts. 19 SRSF3 regulates the expression of neural differentiation-related genes through association with distinct groups of mRNAs. 20 Moreover, SRSF3 is overexpressed in human ovarian cancer, and its knockdown results in apoptosis of ovarian cancer cells. 17 These findings suggest that SRSF3 participates in biological networks crucial for the regulation of cell fate.
In this study, we examined the effects of SRSF3 knockdown in colon cancer cells and found an essential role for SRSF3 in the G1-phase progression and in the regulation of apoptosis. Moreover, we found that alternative splicing of homeodomain-interacting protein kinase-2 (HIPK2) pre-mRNA was SRSF3-dependent. Reduction of SRSF3 preferentially produced a proteasome-resistant isoform. These findings provide new insights into the role of SRSF3 in tumor growth.
RESULTS

SRSF3 knockdown induces G1 arrest and apoptosis
Using two different SRSF3 small interference (si) RNAs (nos. 1 and 2; see Supplementary Table S1 and Supplementary Figure S1 ), we tested whether SRSF3 knockdown caused cell cycle arrest similar to SRSF1-or SRSF2-deficient cells. [11] [12] [13] HCT116 cells were pretreated with control siRNA for 24 h and synchronized in the G1 phase by serum starvation for 48 h. They passed through the cell cycle after the addition of 10% (v/v) fetal calf serum (FCS), with a population doubling time around 24 h (Figure 1a, left panel) . The control cells entered the S phase within 12 h, while the majority of SRSF3 siRNA-treated cells remained in the G1 phase and did not enter the S phase ( Figure 1a , middle and right panels), a result corroborated by the absence of 5-bromo-2 0 -deoxy-uridine (BrdU)-positive cells 12 h after serum stimulation (Figure 1b) . Along with the G1-to-S-phase progression, cyclin D1 levels increased with a peak at 4 h, followed by induction of E2F1 in the S phase (Figure 1c ). The two different siRNAs decreased baseline levels of cyclin D1 and E2F1, and substantially blocked the induction of both cyclin D1 in the G1 phase and E2F1 in the S phase (Figure 1c ).
In association with G1 arrest, SRSF3 knockdown promoted apoptosis; the percentage of cells in the sub-G1 phase increased over time in SRSF3 siRNA-treated cells (Figure 1a ). To control for effects of serum starvation, we examined the effects of SRSF3 siRNAs on HCT116 cells growing in 10% FCS-containing medium (Figure 2) , and confirmed that SRSF3 knockdown cells were arrested in the G1 phase and did not enter the S phase (Figure 2a) . Simultaneously, SRSF3 knockdown cells began to accumulate in the sub-G1 phase within 48 h (Figure 2a) , as the percentages of annexin V-positive cells (Figure 2b ) and activation of caspases 9 and 3 increased (Figure 2c ). SRSF3 knockdown alters the expression of G1/S checkpointrelated genes To determine how SRSF3 knockdown caused G1 arrest, we analyzed differences in gene expression between SRSF3 siRNA no. 1-and control siRNA-treated HCT116 cells. Microarray analysis identified 833 genes whose expression differed by 42-fold between SRSF3 knockdown and control cells; 456 and 377 genes were down-and upregulated in SRSF3 knockdown cells, respectively. Ingenuity Pathway Analysis ranked 'G1/S Checkpoint Regulation' (P ¼ 1.32E À 05) and 'Cyclins and Cell Cycle Regulation' (P ¼ 3.82E À 04) as the top two canonical pathways related to the 833 affected genes (Figure 3a ). There were no changes in the expression of genes encoding cyclin-dependent kinase (CDK) inhibitors, interphase CDKs (CDK4, CDK6 and CDK2) or SRSF3 knockdown downregulates the expression of genes crucial for the G1-to-S-phase progression Quantitative real-time reverse transcription-polymerase chain reaction (qPCR) using specific primer sets (Supplementary Table S2 ) and western blotting with the respective antibodies ( Supplementary Table S3 ) confirmed that the two SRSF3 siRNAs significantly reduced the mRNA (Figure 3c ) and protein levels ( Figure 3d ) of cyclin D1, cyclin D3, E2F1 and E2F7. SRSF3 siRNA no. 1 repressed these mRNAs more effectively than did SRSF3 siRNA no. 2, and cyclin E1 mRNA and protein levels were significantly decreased with the siRNA no. 1. However, CDC25A levels were not affected by either of the two siRNAs (Figures 3c and d) . pRB remained hypophosphorylated without changing its overall expression level (Figure 3d ), indicating the absence of cyclin D-CDK4/6 activation. Moreover, the reduced expression of E2F1 likely increased the impairment of E2F-regulated gene expression, as demonstrated by the reduction of cyclin E1 and E2F7 expression. Among the 833 affected genes in SRSF3 knockdown cells, two antiapoptotic genes were affected differently-BCL2A1 was upregulated and BCL2 was downregulated. Moreover, one proapoptotic gene (BCL2L11) was downregulated. In consistent with a previous study, 17 SRSF3 knockdown decreased BCL2 protein levels to o20% of those in control siRNA-treated cells (Figure 3d ). SRSF1 or SRSF2 deficiency promoted the DDR and G2/M arrest. [11] [12] [13] In the case of SRSF3, however, its knockdown did not phosphorylate histone H2A.X (g-H2A.X, a hallmark of doublestrand breaks) (Figure 4a ). HCT116 cells expressed a small amount of p53. Treatment of HCT116 cells with sodium arsenite induced p53 and phosphorylated p53 Ser15, Ser20 and Ser46 (Figure 4b ). However, SRSF3 knockdown did not induce p53 nor initiate phosphorylation of p53 at Ser15, Ser20 or Ser46 in HCT116 cells (Figure 4b ). Furthermore, we confirmed that SRSF3 knockdown induced G1 arrest in p53-null (p53 À / À ) HCT116 cells (kindly provided by Dr Vogelstein) (Figure 4c ), suggesting that DNA damage-initiated, p53-dependent responses might not be crucial for the G1 arrest in SRSF3 knockdown cells.
Ribonucleoprotein immunoprecipitation (RIP) using an anti-SRSF3 antibody (SRSF3 RIP) or control IgG (IgG RIP) demonstrated that endogenous SRSF3 appeared to associate with CCND3 and Figure 3 . SRSF3 knockdown downregulates the expression of regulators of the G1-to-S-phase progression. (a) Canonical pathways represented by the 833 genes, the expressions of which were changed by 42-fold after SRSF3 knockdown, were analyzed using Ingenuity Pathway Analysis (IPA). The level of significance was set at a P-value of 0.05 by Fisher's exact test. (b) The G1/S checkpoint regulatory network represented by the differentially expressed genes was created using IPA, and genes up-and downregulated by twofold after SRSF3 knockdown are shown in red and green, respectively. Upregulated genes were not included in this network. (c) After treatment of HCT116 cells with 10 nM of the indicated siRNAs for 24 h, changes in CCND1, CCND3, CCNE1, CDC25A, E2F1 and E2F7 mRNA were measured by qPCR using GAPDH mRNA as an endogenous quantity control. Values (means ± s.d., n ¼ 3) are expressed as fold changes compared with those of control siRNA-treated cells. *Po0.05 by analysis of variance (ANOVA) and Bonferroni test. (d) Amounts of cyclins (D1, D3 and E1), CDC25A, E2F1, E2F7, pRB, phosphorylated pRB and BCL2 proteins in these cells were measured by western blotting using b-actin a loading control.
E2F1 and, to a lesser extent, with CCND1 and CCNE1 mRNAs (Supplementary Figure S2) , whereas SRSF3 knockdown did not change the stability of these mRNAs (Supplementary Figure S3) . SRSF3 knockdown changes alternative splicing of HIPK2 pre-mRNA Decreased expression of BCL2 protein may be responsible for the induction of apoptosis after SRSF3 silencing. We also examined the possibility that SRSF3 silencing might cause aberrant splicing of pre-mRNAs crucial for apoptosis. Alternative splicing events were compared between SRSF3 siRNA no. 1-and control siRNAtreated cells using the GeneChip Human Exon 1.0 ST Array (Affymetrix, Santa Clara, CA, USA). Three independent experiments detected SRSF3-dependent alternative splicing events with significant splicing indices (SIs) (Po0.05 and SI41.0) in 122 genes. Using the UCSC genome browser, we found that 11 of those genes (HIPK2, E2F1, E2F7, CDC2L5, COPS4, HRB, HSPA14, RBM33, SRCAP, SRF and WNK1) appeared to change alternative splicing patterns within their open reading frames. The predicted changes in alternative splicing in HIPK2, E2F1 and E2F7 pre-mRNAs ( Figure 5a ) were detected by RT-PCR (Figure 5b ), while we could not confirm alternative splicing of the other genes. RT-PCR analysis of HIPK2 showed that the exon 8-containing transcript became undetectable and there was a concomitant increase in a smaller transcript after SRSF3 knockdown (Figure 5b Alternative splicing of HIPK2 pre-mRNA facilitates apoptosis From qPCR, HCT116 cells expressed around 20% of total HIPK2 transcripts as HIPK2 De8 mRNA. SRSF3 knockdown led to preferential production of the HIPK2 De8 isoform without significantly changing total HIPK2 transcript levels ( Figure 5c , left panel). To elucidate the significance of this alternative splicing, we designed three HIPK2 siRNAs (Supplementary Table S1 ): no. 1 targeted both HIPK2 FL and De8 mRNAs, whereas nos. 2 and 3, which targeted different sequences in the 81 5 0 -nt of exon 8, reduced only the HIPK2 FL isoform (Figure 6a ). As noted by others, 21 we could not detect endogenous HIPK2 protein using any commercially available antibodies. We therefore transfected plasmids encoding FLAG-HIPK2 FL or De8 cDNA and confirmed that HIPK2 siRNA no. 1 almost completely knocked down both FLAG-HIPK2 FL and De8 proteins, whereas HIPK2 siRNAs nos. 2 and 3 selectively decreased FLAG-HIPK2 FL levels (Figure 6b) .
HIPK2 is an antioncogene that induces tumor cell apoptosis. 22, 23 Loss of HIPK2 increases proliferative potential. 24 However, it should be noted that selective HIPK2 FL knockdown with HIPK2 siRNA no. À / À HCT116 cells were treated with 10 nM control or SRSF3 siRNAs for 24 h, synchronized in the G1 phase by serum starvation for 48 h, and then stimulated with 10% FCS for the indicated times. These cells were stained with PI and subjected to fluorescence activated cell sorter (FACS) analysis. Raw data were quantitated by the FlowJo software.
SRSF3 controls G1/S transition and apoptosis K Kurokawa et al cells (Figure 6c (lower panels) and Figure 6d ). HIPK2 siRNA no. 2 activated caspase-3 in mutant p53-expressing colon cancer cell lines (HT-29, T84, Caco-2 and SW480) and wild-type p53-expressing RKO cells (Figure 6d ). These results suggested that selective degradation of HIPK2 FL might stimulate both p53-dependent and -independent apoptotic pathways. SRSF3 were ubiquitously expressed in various types of cells (Supplementary Figure S4a) . SRSF3 knockdown induced the skipping of the 81 5 0 -nt of HIPK2 exon 8 in all colon cancer cell lines tested (Supplementary Figure S4b) and facilitated caspase-3 processing in those cells (Supplementary Figure S4c) .
The 81 5 0 -nt of HIPK2 exon 8 encodes 27 amino acids. Their absence does not alter the following translational reading frame. The 27 amino acids constitute a part of the binding site for the E3 ubiquitin ligase Siah-1. 25 Unstressed cells constantly degrade HIPK2 through the ubiquitin-proteasome system. [25] [26] [27] [28] Genotoxic stress stabilizes HIPK2 through dissociation of Siah-1 from HIPK2. 25, 29 Once activated, HIPK2 interacts with diverse downstream targets and activates apoptosis. 30, 31 After transfection of a plasmid encoding FLAG-HIPK2 FL or De8 cDNA into HCT116 cells, the stabilities of the two proteins were monitored in the presence of cycloheximide. As expected, FLAG-HIPK2 FL protein was degraded, whereas HIPK2 De8 levels remained constant (Figures 7a and b) . In addition, a proteasome inhibitor (MG-132) blocked the degradation of FLAG-HIPK2 FL, but it did not affect FLAG-HIPK2 De8 levels (Figure 7c ). Using HCT116 cells overexpressing FLAG-HIPK2 FL or De8, we found that endogenous Siah-1 could not associate with FLAG-HIPK2 De8 (Figure 7d ). Thus, HIPK2 De8 was likely to exhibit greater resistance to proteasome digestion.
Phosphorylation of p53 at Ser46 by HIPK2 De8 HIPK2 phosphorylates p53 at Ser46 and activates apoptotic p53 target genes. 22, 23 We examined whether HIPK2 De8 could phosphorylate p53 at Ser46. For this purpose, we used HEK293T cells, as HEK293T cells constitutively expressed larger amounts of p53 and were more suitable for the transfection experiments. First, we confirmed that overexpressed FLAG-HIPK2 De8 dose-dependently phosphorylated p53 at Ser46 in HEK293T cells, whose endogenous HIPK2 FL and De8 were silenced with an siRNA targeting HIPK2 3 0 -UTR ( Figure 8a ). Next, FLAG-HIPK2 FL or De8 was overexpressed at similar levels in HIPK2 3 0 -UTR siRNA-treated HEK293T cells. Using these cells, we confirmed that overexpressed FLAG-HIPK2 FL and FLAG-HIPK2 De8 similarly phosphorylated p53 at Ser46 (Figure 8b ) and initiated caspase-3 processing in response to a sublethal concentration of Adriamycin (Figure 8c) . In HEK293T cells, the knockdown of SRSF3 changed the alternative splicing to preferentially produce HIPK2 De8 isoform (Supplementary Figure  S5a) . We also confirmed that SRSF3 silencing activated caspase-3 (Supplementary Figure S5b) . However, SRSF3 silencing induced p53 Ser46 phosphorylation to a much lesser extent, when compared with arsenite treatment (Supplementary Figure S5c) . 
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We also found that selective knockdown of HIPK2 FL with HIPK2 siRNA no. 2 did not specifically phosphorylate p53 at Ser46 (Supplementary Figure S5d) . Finally, we examined whether carboxyl-terminal binding protein (CtBP) was involved in the apoptotic induction after knockdown of SRSF3 or HIPK2 FL in HCT116 cells. SRSF3 knockdown did not decrease CtBP levels in HCT116 cells (Supplementary Figure S6a) . Selective HIPK2 FL knockdown with HIPK2 siRNA no. 2 as well as knockdown of both HIPK2 FL and De8 with HIPK2 siRNA no. 1 did not reduce CtBP levels in HCT116 cells (Supplementary Figure  S6b) . Furthermore, we could not detect any significant association between CtBP and FLAG-HIPK2 FL or De8 in our experimental conditions (Supplementary Figure S6c) . DISCUSSION SRSF family members have wide-ranging roles in the regulation of transcription and post-splicing processes, which are essential for proper cell cycle control. In contrast to the G2/M cell cycle arrest in SRSF1-or SRSF2-deficient cells, [11] [12] [13] 32 we report here that SRSF3 silencing causes G1 arrest in association with the downregulation of a group of genes encoding G1/S checkpoint regulators. DDRs resulting from cotranscriptional R-loop formation are suggested to be one of the mechanisms for the cell cycle defects in SRSF1-depleted cells. 11 However, we could not detect a sign of double-strand DNA breaks after SRSF3 knockdown. Moreover, SRSF3 downregulation initiated G1 arrest in p53 À / À cells. These results suggest that p53- SRSF3 controls G1/S transition and apoptosis K Kurokawa et al dependent DDRs may not be the main cause of G1 arrest after SRSF3 knockdown. As in SRSF1-and SRSF2-deficient cells, 3 a widespread defect in Pol II-mediated transcription could be another possible mechanism for SRSF3 knockdown-induced G1 arrest. SRSF2 depletion attenuates the association of P-TEFb with Pol II and blocks CTD Ser2 phosphorylation, resulting in decreased transcriptional elongation in a gene-specific manner.
3 A large Figure 7 . Association of HIPK2 proteins with Siah-1. (a) P53 þ / þ HCT116 cells were transfected with a plasmid encoding FLAG-HIPK2 FL or De8 cDNA for 24 h. Before (0) or 3, 6, 9 and 12 h after treatment of these cells with 25 mM cycloheximide (CHX), remaining HIPK2 protein levels were assayed by western blotting using an anti-FLAG antibody. a-Tubulin was used as a loading control. (b) The time-dependent changes in FLAG-HIPK2 FL or De8 levels measured by western blotting were quantified by densitometry, and the remaining HIPK2 protein levels were plotted as percentages of those measured at time 0 (100%). Values are means±s.d. (n ¼ 3). (c) After transfection with a plasmid encoding FLAG-HIPK2 FL or De8 for 24 h, HCT116 cells were untreated or treated with 5 mM MG-132 in the presence of 25 mM CHX for 12 h. Whole-cell lysates were prepared from these cells, and the amounts of FLAG-HIPK2 FL or De8 were measured by western blotting. Similar results were obtained in three independent experiments. (d) After transfection with a FLAG-HIPK2 FL-or De8-encoding plasmid for 24 h, p53
þ / þ HCT116 cells were treated with 10 mM MG-132 for 6 h. FLAG-HIPK2 FL or De8 associated with endogenous Siah-1 was immunoprecipitated using an anti-Siah-1 antibody. Immunoprecipitated FLAG-HIPK2 FL or De8 was analyzed by western blotting using an anti-FLAG antibody. Normal goat IgG was used for control immunoprecipitation. Similar results were obtained in four independent experiments. Table S1 ). The indicated amounts of a plasmid expressing FLAG-tagged HIPK2 De8 or mock were transfected in HEK293T cells for 24 h and overexpressed FLAG-HIPK2 De8, total p53 and phosphorylated p53 at Ser46 were measured by western blotting. (b) Similar amounts of FLAG-HIPK2 FL or De8 were overexpressed in HIPK2 3 0 -UTR siRNA-treated HEK293T cells. Total and phosphorylated p53 at Ser46 were measured by western blotting. HIPK2 3 0 -UTR siRNA-treated and mock-transfected cells were used as controls. (c) After treatment of HEK293T cells with HIPK2 3 0 -UTR siRNA and transfection with mock or a plasmid encoding HIPK2 FL or De8 cDNA, the amounts of unprocessed and activated caspase-3 in the cells untreated or treated with a sublethal dose of Adriamycin (0.5 mg/ml) were measured by western blotting. Similar results were obtained in four independent experiments. SRSF3 controls G1/S transition and apoptosis K Kurokawa et al SR-related protein (SON) supports the interaction between SRSF2 and RNA Pol II, and contributes to efficient SRSF2-dependent cotranscriptional RNA processing. SON knockdown causes multiple defects in mitotic chromosomal arrangement, spindle pole separation and microtubule dynamics. These defects result from inadequate RNA splicing of a specific set of cell cycle-related genes. 10 SRSF1 associates with interphase chromatin, dissociates from mitotic chromatin and re-associates with postmitotic chromatin in a histone H3 modification-sensitive manner.
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SRSF1 knockdown impairs chromosomal segregation and M-phase progression. 33 Thus, both SRSF1 and SRSF2 are suggested to be essential for the G2/M-phase progression, whereas SRSF3 might be more selective for the regulation of the G1-to-S-phase progression.
The first kinase complexes to become active in the G1 phase are cyclin D/CDK4/6 that initiate phosphorylation of RB family proteins and release E2F1 from the RB-repressor complex, permitting transcription essential for the G1/S transition. Here, SRSF3 knockdown significantly suppressed both basal levels and serum-stimulated induction of cyclins D1. At the same time, it also downregulated E2F1 expression. Consequently, pRB remained hypophosphorylated, and E2F downstream targets, cyclin E1 and E2F7, were not induced in SRSF3 knockdown cells. RIP analysis showed that SRSF3 bound to CCND1, CCND3 and E2F1 mRNAs and its knockdown decreased their expression, whereas treatment with SRSF3 siRNAs did not change their stabilities. These results suggest that SRSF3 downregulation may suppress transcription of these G1/S transition-related genes.
SRSF3 knockdown also caused apoptosis. Many apoptotic factors are expressed through alternative splicing, generating isoforms with antagonistic effects. 34 SRSF1 is known to regulate alternative splicing of the BCL2 family of genes.
14 Although we could not detect any changes in alternative splicing of the BCL2 family of genes in SRSF3 knockdown cells, SRSF3 silencing reduced the expression of BCL2 protein as reported previously, 17 which may be one of the mechanisms for the apoptosis after SRSF3 silencing. We also examined the possibility that SRSF3 silencing might cause aberrant splicing of pre-mRNAs crucial for apoptosis, and found that SRSF3 knockdown facilitated the switching from the full-length HIPK2 mRNA isoform (HIPK2 FL) to an isoform lacking the 81 5 0 -nt of HIPK2 exon 8 (HIPK2 De8). HIPK2 was first identified as a corepressor for homeodomain transcription factors. 35 Subsequently, it was found to be a DNA damage-responsive kinase that forms a complex with p53 and phosphorylates p53 at Ser46, which in turn activates apoptotic p53 target genes. 22, 23 In fact, apoptotic signs were absent when both HIPK2 FL and HIPK2 De8 were silenced. Unexpectedly, however, the selective degradation of HIPK2 FL mRNA facilitated apoptosis. These results led us to speculate that cells predominantly expressing HIPK2 De8 rather than HIPK2 FL might incline to undergo apoptosis. However, to date, any specific functional difference between HIPK2 FL and HIPK2 De8
has not yet been documented.
HIPK2 FL and HIPK2 De8 displayed similar nuclear distribution patterns and both interacted with US11 protein of herpes simplex virus type 1. 36 In addition to p53 and homeoproteins, HIPK2 interacts with several other proteins. 21, 24, [37] [38] [39] [40] [41] The 27 amino acids constitute a part of the binding site for the E3 ubiquitin ligase Siah-1. 25 As a result, HIPK2 De8 did not associate with Siah-1 and was resistant to proteasome digestion. Using HEK293T cells, in which endogenous HIPK2 was silenced by siRNA targeting HIPK2 3 0 -UTR, we confirmed that overexpressed FLAG-HIPK2 De8 could phosphorylate p53 Ser46, similar to overexpressed FLAG-HIPK2 FL. Moreover, cells overexpressing FLAG-HIPK2 De8 were inclined to undergo apoptosis.
SRSF3 knockdown directly or indirectly changed a wide variety of gene expression and post-transcriptional processing. It might modify multiple pro-and antiapoptotic pathways that have not yet been clarified in this study. At present, it is difficult to interpret the decisive cause of the apoptosis. Moreover, we hardly know to what extent the alternative splicing of HIPK2 contributes to the apoptosis after SRSF3 knockdown. The apoptosis caused by knockdown of SRSF3 or HIPK2 FL was partially blocked in p53-null HCT116 cells. However, SRSF3 or HIPK2 FL knockdown-induced phosphorylation of p53 at Ser46 was insufficient. Silencing of SRSF3 or selective HIPK2 FL knockdown could induce apoptosis in colon cancer cell lines expressing mutated p53. Thus, SRSF3 or HIPK2 FL silencing may be able to activate both p53-dependent and -independent apoptotic pathways. HIPK2 regulates both p53-dependent and -independent apoptosis in response to genotoxic damage. 30, 42 Particularly, HIPK2 regulates apoptosis by modulating molecules independently by p53, such as through phosphorylation-dependent degradation of antiapoptotic transcriptional corepressor CtBP. 37 However, we could not detect any reduction of CtBP after silencing of SRSF3 or HIPK2 FL. Colon cancer cells frequently inactivate p53; therefore, p53-independent apoptotic pathway may be more important in human colon cancers. Further studies are needed to elucidate the precise mechanism for the apoptotic induction.
Increased expression of SRSF3 may be associated with malignancy of several tumors. 17 Our findings provide mechanistic insights into the role of SRSF3 in tumor growth. Moreover, we have uncovered an unexpected mechanism of cell fate regulation involving alternative splicing of HIPK2. Use of the siRNA technique selectively targeting HIPK2 FL represents a potential therapeutic strategy, even against p53-mutated cancer cells. Table S1 ). For HIPK2 mRNA, we designed three siRNAs: one (no. 1) targeting both HIPK2 FL and De8 mRNAs, and the other two (nos. 2 and 3) targeting only HIPK2 FL mRNA (Supplementary Table S1 ). The Stealth RNAi-negative control (Invitrogen) was used as a control siRNA. Cells were transfected with the indicated siRNAs at a final concentration of 10 nM using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's instructions.
MATERIALS AND METHODS
Plasmid construction A cDNA library was prepared from p53 þ / þ HCT116 cells, and the human SRSF3 open reading frame (NM_003017.4) was amplified by PCR using a primer set: 5 0 -AAAAAAGGATCCATGCATCGTGATTCCTGTCCATTG-3 0 (forward; underline indicates BamHI site) and 5 0 -AAAAAAGATATC CTATTTCCTTTCATTTGACCTAGA-3 0 (reverse; underline indicates EcoRV site). Both HIPK2 FL and HIPK2 De8 open reading frames were amplified using primer sets: 5 0 -AAAAGAATTCATGGCCCCCGTGTACGAAGGTATGG-3 0 (forward; underline indicates EcoRI site) and 5 0 -AAAACTCGAGTAT GTAAGGGTACTGGTTGACCTTG-3 0 (reverse; underline indicates XhoI site), and separated using a gel extraction kit (Qiagen, Hilden, Germany). The amplified products were cloned into the mammalian expression vector pCMV-3Tag (Stratagene, La Jolla, CA, USA). FLAG was appended to the NH 2 termini of SRSF3 and HIPK2. All constructs were confirmed to have the expected sequence by DNA sequencing. These plasmids were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions.
RT-PCR and qPCR
Total RNA was isolated using the RNeasy mini Kit (Qiagen), and contaminating DNA was removed with a RNase-Free DNase Set (Qiagen). The quantity was measured with an ND-1000 (NanoDrop, Wilmington, DE, USA). cDNA was synthesized from 1 mg of total RNA using a PrimeScript RTase Synthesis Kit (Takara, Shiga, Japan). Primer sequences are shown in SRSF3 controls G1/S transition and apoptosis K Kurokawa et al
